SHH and nasopharyngeal carcinoma: Therapeutically, successful abrogation of NPC hyperproliferation and tumorigenesis as a result of aberrant GLI expression has been achieved using the SHH signaling inhibitor, cylcopamine (Berman et al., 2002; Altaba et al., 2004).